Kevin Winthrop MD, MPHProfessor Epidemiology & Epidemiology and Medicine
Kevin L. Winthrop, Professor of Public Health, Infectious Diseases, and Ophthalmology at Oregon Health and Science University, is a former staff infectious disease epidemiologist from the U.S. Centers for Disease Control and Prevention’s Division of Tuberculosis Elimination. He has co-authored over 225 publications, many detailing the epidemiologic and clinical aspects of nontuberculous mycobacterial diseases (NTM), tuberculosis, and other infections associated with rheumatic diseases and biologic immunosuppressive therapies. Clinically, he provides regional consultations for mycobacterial diseases and other chronic chest infections and serves as the medical consultant to the Oregon Public Health Division’s TB control program. His Center for Infectious Disease Studies has served as the lead institution and coordinating center for multiple cohort studies and clinical trials. He has served as a primary or senior investigator in many of these clinical and epidemiologic studies, and frequently collaborates with the Pulmonary Department on studies related to bronchiectasis, as well as with the Rheumatology Department on studies related to biologic immunosuppressive therapies. He founded the NTM Research Consortium and associated Clinical Trials Network which facilitate collaborative, multi-site grants and clinical trials among patients with NTM.
He is also a member of the graduate faculty at OHSU, where he mentors public health students, medical students, and physicians in post-graduate training.
M.P.H., Epidemiology, University of California at Berkeley, 2003
M.D., Oregon Health & Science University, 1998
B.A., Biology, Yale University, 1993
Awards and Honors
- 2012, Gary D. Friedman Outstanding Paper Award, Kaiser Permanente Medical Care Program Division of Research
- 2010, Richard T. Jones New Investigator Award, Medical Research Foundation of Oregon
- 2004, Outstanding Unit Citation Award, United States Public Health Service, given for investigation of hepatotoxicity associated with a new tuberculosis treatment. Investigation resulted in new recommendations for the treatment of tuberculosis infection.
- 2003, Commendation Medal, United States Public Health Service, given for national leadership in the surveillance, prevention and treatment of mycobacterial skin infections in the United States.
- 2002, Outstanding Unit Citation Award, United States Public Health Service
- RO1 FD005401 (Winthrop) 09/01/16 – 07/31/20
- UM1 AR065705 (Curtis/Winthrop)09/01/14 – 08/01/19
- ATS Junior Faculty (Henkle/Winthrop) 12/15/16 – 12/14/18
- HHSN272201200005C (Topham) 12/13/11-12/12/18
- 1013-OHSU (Winthrop) 05/01/15-04/30/16
- Arikace TR02-112 4/12/12-11/20/15
- CST001_USA4 (Winthrop) 07/15/14 – 06/30/15
- S-SRA (Curtis/Winthrop) 7/1/2013 – 6/30/2015